{{Rsnum
|rsid=1350172
|Chromosome=10
|position=63348767
|Orientation=plus
|GMAF=0.3981
|Assembly=GRCh37.p5
|GenomeBuild=37.3
|dbSNPBuild=137
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 10.6 | 53.1 | 36.3
| HCB | 37.2 | 46.7 | 16.1
| JPT | 31.0 | 54.0 | 15.0
| YRI | 10.9 | 38.8 | 50.3
| ASW | 8.8 | 49.1 | 42.1
| CHB | 37.2 | 46.7 | 16.1
| CHD | 39.4 | 40.4 | 20.2
| GIH | 25.7 | 44.6 | 29.7
| LWK | 3.6 | 33.6 | 62.7
| MEX | 12.1 | 32.8 | 55.2
| MKK | 6.4 | 43.6 | 50.0
| TSI | 12.7 | 45.1 | 42.2
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23006423
  |Trait=Response to taxane treatment (placlitaxel)
  |Title=Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.
  |RiskAllele=
  |Pval=4E-7
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | Illumina Human 1M}}